OpGen - Spezialist gegen antibiotikaresistente Infektionen (Seite 10)
eröffnet am 13.08.15 09:48:54 von
neuester Beitrag 10.11.23 14:21:39 von
neuester Beitrag 10.11.23 14:21:39 von
Beiträge: 402
ID: 1.217.076
ID: 1.217.076
Aufrufe heute: 0
Gesamt: 36.933
Gesamt: 36.933
Aktive User: 0
ISIN: US68373L4068 · WKN: A3D38S · Symbol: OPGN
0,5100
USD
-5,54 %
-0,0299 USD
Letzter Kurs 02:00:00 NYSE
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,9000 | +59,66 | |
| 0,5922 | +44,44 | |
| 7,3500 | +43,84 | |
| 11,690 | +40,84 | |
| 0,7000 | +36,69 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 10,110 | -13,44 | |
| 8,2200 | -13,47 | |
| 7,6100 | -17,20 | |
| 1,6100 | -18,27 | |
| 2,1200 | -21,77 |
Beitrag zu dieser Diskussion schreiben
FeedbackNeue Zyklik, neues Glück.
Die Analysten halten OpGen Inc für unterbewertet:
OpGen – Consensus Indicates Potential 167.0% Upside
OpGen found using ticker (OPGN) have now 2 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 7 and 4 and has a mean target at 5.5. With the stocks previous close at 2.06 this would imply there is a potential upside of 167.0%.
https://www.directorstalkinterviews.com/opgen---consensus-in…
Chart:
Auch hier ein ähnliches Bild wie derzeit bei vielen Nasdaq-Werten.
Der Kurs korrigierte und ist jetzt in der Nähe einer Unterstützung.
💡
Die fast schon obligatorische Halbjahresspitze ging bis fast $ 4,40:
🎵
🎵
Antwort auf Beitrag Nr.: 66.890.108 von manffreddoo am 08.02.21 20:27:22
Hab ca.3/4 eben verkauft. Sieht mir schwer nach Hype auf dem gesamtem Biotec-Markt aus. Ich hoffe auf günstigere Eindtiegskurse. Aber für den Fall der Fälle hab ich ja noch etwas im Depot.
Zitat von manffreddoo: Hi,
und ab geht die Post.
Ich bleib noch drinn ein paar Tage.
Könnte weiter gehen mit dem Höhenflug
M.
Hab ca.3/4 eben verkauft. Sieht mir schwer nach Hype auf dem gesamtem Biotec-Markt aus. Ich hoffe auf günstigere Eindtiegskurse. Aber für den Fall der Fälle hab ich ja noch etwas im Depot.
Antwort auf Beitrag Nr.: 66.869.216 von Malecon am 07.02.21 19:32:54 Hi,
und ab geht die Post.
Ich bleib noch drinn ein paar Tage.
Könnte weiter gehen mit dem Höhenflug
M.
und ab geht die Post.
Ich bleib noch drinn ein paar Tage.
Könnte weiter gehen mit dem Höhenflug
M.
Die fast schon obligatorische Halbjahres-Unruhe fängt bei OpGen Inc an, da kannste die Uhr danach stellen:
💡
Trading Spotlight
das Ding hier sit eht , nur noch für die Tonne...
Antwort auf Beitrag Nr.: 65.903.136 von Erdman am 01.12.20 12:05:48PLAN OF DISTRIBUTION
The selling stockholder, and its pledgees, donees, transferees or other successors in interest, may from time to time offer and sell, separately or together, some or all of the Securities covered by this prospectus. Registration of the Securities covered by this prospectus does not mean, however, that those Securities necessarily will be offered or sold.
The Securities covered by this prospectus may be sold from time to time, at market prices prevailing at the time of sale, at prices related to market prices, at a fixed price or prices subject to change or at negotiated prices, by a variety of methods including the following:
· in the Nasdaq Capital Market;
· in privately negotiated transactions;
· through broker-dealers, who may act as agents or principals;
· through one or more underwriters on a firm commitment or best-efforts basis;
· in a block trade in which a broker-dealer will attempt to sell a block of securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;
· directly to one or more purchasers;
· through agents; or
· in any combination of the above.
In effecting sales, brokers or dealers engaged by the selling stockholder may arrange for other brokers or dealers to participate. Broker-dealer transactions may include:
· purchases of the Securities by a broker-dealer as principal and resales of the Securities by the broker-dealer for its account pursuant to this prospectus;
· ordinary brokerage transactions; or
· transactions in which the broker-dealer solicits purchasers on a best efforts basis.
Ob das jetzt eine echte Spekulanten Aktie wird?
Dann viel Spass beim Traden.
The selling stockholder, and its pledgees, donees, transferees or other successors in interest, may from time to time offer and sell, separately or together, some or all of the Securities covered by this prospectus. Registration of the Securities covered by this prospectus does not mean, however, that those Securities necessarily will be offered or sold.
The Securities covered by this prospectus may be sold from time to time, at market prices prevailing at the time of sale, at prices related to market prices, at a fixed price or prices subject to change or at negotiated prices, by a variety of methods including the following:
· in the Nasdaq Capital Market;
· in privately negotiated transactions;
· through broker-dealers, who may act as agents or principals;
· through one or more underwriters on a firm commitment or best-efforts basis;
· in a block trade in which a broker-dealer will attempt to sell a block of securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;
· directly to one or more purchasers;
· through agents; or
· in any combination of the above.
In effecting sales, brokers or dealers engaged by the selling stockholder may arrange for other brokers or dealers to participate. Broker-dealer transactions may include:
· purchases of the Securities by a broker-dealer as principal and resales of the Securities by the broker-dealer for its account pursuant to this prospectus;
· ordinary brokerage transactions; or
· transactions in which the broker-dealer solicits purchasers on a best efforts basis.
Ob das jetzt eine echte Spekulanten Aktie wird?
Dann viel Spass beim Traden.
Antwort auf Beitrag Nr.: 65.902.947 von Erdman am 01.12.20 11:55:44SELLING STOCKHOLDER
We have prepared this prospectus to allow the selling stockholder to sell or otherwise dispose of, from time to time, up to 2,245,400 Shares of Common Stock, 2,597,215 Pre-Funded Warrant Shares, and 4,842,615 Common Warrant Shares.
Armistice Capital, LLC
The investment manager of the selling stockholder, and Steven J. Boyd, the managing member of Armistice Capital, LLC hold shared voting and dispositive power over the shares of common stock and warrants held by the selling stockholder. The address for the selling stockholder is 510 Madison Avenue, 7th Floor, New York, NY 10022.
Shares up to date: 2,245,400
New shares and rights: 9,685,230
Source: https://ir.opgen.com/node/10156/html
We have prepared this prospectus to allow the selling stockholder to sell or otherwise dispose of, from time to time, up to 2,245,400 Shares of Common Stock, 2,597,215 Pre-Funded Warrant Shares, and 4,842,615 Common Warrant Shares.
Armistice Capital, LLC
The investment manager of the selling stockholder, and Steven J. Boyd, the managing member of Armistice Capital, LLC hold shared voting and dispositive power over the shares of common stock and warrants held by the selling stockholder. The address for the selling stockholder is 510 Madison Avenue, 7th Floor, New York, NY 10022.
Shares up to date: 2,245,400
New shares and rights: 9,685,230
Source: https://ir.opgen.com/node/10156/html
aus dem SEC filing:
RISK FACTORS
Investing in our securities involves substantial risks.
In addition to other information contained in this prospectus and in any accompanying prospectus supplement, before investing in our securities, you should carefully consider the risks described under the heading “Risk Factors” in our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q and any subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K and in any other documents incorporated by reference into this prospectus, as updated by our future filings. These risks are not the only ones faced by us. Additional risks not known or that are deemed immaterial could also materially and adversely affect our financial condition, results of operations, our products, business and prospects. Any of these risks might cause you to lose all or a part of your investment.
The number of shares being registered for resale is significant in relation to the number of our outstanding shares of Common Stock.
We have filed a registration statement of which this prospectus is a part to register the shares offered hereunder for sale into the public market by the selling stockholder. These shares represent a large number of shares of our Common Stock, and if sold in the market all at once or at about the same time, could depress the market price of our Common Stock during the period the registration statement remains effective and could also affect our ability to raise equity capital.
USE OF PROCEEDS
We will not receive any of the proceeds from the sale or other disposition of the Securities held by the selling stockholder pursuant to this prospectus.
Da wird also in den nächsten Monaten und in 2021 einiges in den Markt kommen.
Andererseits spekuliert auch der Käufer und Verkäufer auf steigende Kurse.
RISK FACTORS
Investing in our securities involves substantial risks.
In addition to other information contained in this prospectus and in any accompanying prospectus supplement, before investing in our securities, you should carefully consider the risks described under the heading “Risk Factors” in our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q and any subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K and in any other documents incorporated by reference into this prospectus, as updated by our future filings. These risks are not the only ones faced by us. Additional risks not known or that are deemed immaterial could also materially and adversely affect our financial condition, results of operations, our products, business and prospects. Any of these risks might cause you to lose all or a part of your investment.
The number of shares being registered for resale is significant in relation to the number of our outstanding shares of Common Stock.
We have filed a registration statement of which this prospectus is a part to register the shares offered hereunder for sale into the public market by the selling stockholder. These shares represent a large number of shares of our Common Stock, and if sold in the market all at once or at about the same time, could depress the market price of our Common Stock during the period the registration statement remains effective and could also affect our ability to raise equity capital.
USE OF PROCEEDS
We will not receive any of the proceeds from the sale or other disposition of the Securities held by the selling stockholder pursuant to this prospectus.
Da wird also in den nächsten Monaten und in 2021 einiges in den Markt kommen.
Andererseits spekuliert auch der Käufer und Verkäufer auf steigende Kurse.
Antwort auf Beitrag Nr.: 65.886.006 von Secondjob am 30.11.20 11:16:26Bin noch dabei und sehe die mittlere Zukunft hier positiv.
Durchsuchen
